Suzhou Omini Pharmaceutical specializes in the development of inhalation particle compositions, particularly for treating asthma and chronic obstructive pulmonary diseases
Suzhou Omini Pharmaceutical specializes in the development of inhalation particle compositions, particularly for treating asthma and chronic obstructive pulmonary diseases. Their innovative preparation methods focus on improving the bulk density and fluidity of inhalation powders.